IL6 and neoplasm: Specifically, JAK-STAT signaling, triggered by the IL6/sIL-6Rα complex, activates extracellular signal-regulated protein kinase 1 and 2 and phosphoinositide 3-kinase downstream pathways that have been implicated in tumor cell growth [54,57,58,59].